Table II.
Summary of Recommendations for HBPM
| Procedure | Recommendation |
|---|---|
| Technical aspects of BP measurement | Measure BP: |
| • No tobacco or caffeine for 30 minutes preceding measurement | |
| • After 5 minutes rest | |
| • With arm at heart level; back supported and feet flat on the ground | |
| • On nondominant arm (or arm with the highest BP) | |
| BP monitor | • Use a fully automated device with an upper arm cuff that has been validated by BHS, AAMI, or International Protocol for the Validation of Automated BP Measuring Devices |
| • Monitors with memory that are able to store measurements are preferred | |
| Training of patients | • Patients should be trained by their health care provider, and the monitor readings checked against mercury |
| • Education content: hypertension and cardiovascular risk, BP measurement procedure, use of a validated monitor, cuff size, protocols for measuring BP, interpretation of BP readings, and monitor for their use only | |
| • Reevaluate patient technique and the accuracy of the device annually | |
| Target BP goal | • 135/85 mm Hg, or 130/80 mm Hg if patient has diabetes, coronary heart disease, or chronic kidney disease (Class IIa; Level of Evidence B) |
| Frequency and schedule of measurement | Initial values (when patients begin HBPM): |
| • Base decisions on a 7‐day measurement period with 2–3 measurements each morning and 2 to 3 measurements in the evening at prestipulated times (an average of 12 morning and evening measurements) | |
| • Exclude first‐day measurements from the analyses; take average of these values as the reference parameter in the subsequent dose‐titration phase | |
| Dose‐titration phase (titration of initial dose and adjustment of therapy): | |
| • All measurements should be made under identical conditions and at the same times of day as the initial values | |
| • HBPM data should be ascertained as trough values (ie, before medication is taken) in the morning and again at night | |
| • Use the average of BPs measured over 2 to 4 weeks to assess the effect of treatment | |
| Long‐term observation: | |
| • For stable normotensive (controlled) patients, patients should conduct HBPM a minimum of 1 week per quarter (an average of 12 morning and evening measurements under conditions described above) | |
| • Measurement should be made more frequently in patients with poor compliance | |
| Abbreviations: AAMI, Association for the Advancement of Medical Instrumentation; BHS, British Hypertension Society; BP, blood pressure; HBPM, home blood pressure monitoring. | |